1.上海中医药大学附属岳阳中西医结合医院治未病二科(上海 200437)
2.上海中医药大学附属曙光医院肝病二科(上海 201203)
周扬,男,博士,副主任医师,主要从事传统中医临床与研究工作
刘成海,教授;E-mail:chenghailiu@hotmail.com
扫 描 看 全 文
周扬, 邢枫, 赵长青, 等. 徒都子补气汤加减联合西医常规疗法治疗肝硬化顽固性腹水的临床观察[J]. 上海中医药杂志, 2021,55(5):67-69,76.
Yang ZHOU, Feng XING, Changqing ZHAO, et al. Clinical observation on treatment of refractory ascites in liver cirrhosis by modified Tuduzi Buqi Decoction combined with western medicine conventional therapy[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(5):67-69,76.
周扬, 邢枫, 赵长青, 等. 徒都子补气汤加减联合西医常规疗法治疗肝硬化顽固性腹水的临床观察[J]. 上海中医药杂志, 2021,55(5):67-69,76. DOI: 10.16305/j.1007-1334.2021.2011059.
Yang ZHOU, Feng XING, Changqing ZHAO, et al. Clinical observation on treatment of refractory ascites in liver cirrhosis by modified Tuduzi Buqi Decoction combined with western medicine conventional therapy[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(5):67-69,76. DOI: 10.16305/j.1007-1334.2021.2011059.
目的,2,观察徒都子补气汤加减联合西医常规疗法治疗肝硬化顽固性腹水的临床疗效。,方法,2,将57例肝硬化顽固性腹水患者分为治疗组(32例)和对照组(25例)。对照组采用西医常规治疗,治疗组在西医常规治疗的基础上加用徒都子补气汤,两组疗程均为14 d。观察比较腹水相关指标(24 h尿量、体质量、腹围、仰卧位腹水深度)及实验室相关指标(肝功能、肾功能、电解质、凝血功能)的变化情况。,结果,2,①治疗7 d与治疗前组内比较,治疗组24 h尿量增加(,P,<,0.05),体质量、腹围、仰卧位腹水深度减少(,P,<,0.05),对照组上述指标差异无统计学意义(,P,>,0.05);治疗14 d与治疗前组内比较,两组上述腹水相关指标差异有统计学意义(,P,<,0.05)。治疗7 d、治疗14 d组间比较,24 h尿量、仰卧位腹水深度差异有统计学意义(,P,<,0.05)。②治疗14 d与治疗前组内比较,对照组血清肌酐水平升高(,P,>,0.05),治疗组肝功能、肾功能、电解质、凝血功能相关指标差异无统计学意义(,P,>,0.05)。治疗14 d组间比较,上述指标差异均无统计学意义(,P,>,0.05)。,结论,2,相较于单纯采用西医常规疗法,加用徒都子补气汤更有助于肝硬化顽固性腹水的消退,且未增加肾功能损伤、电解质紊乱的风险。
Objective,2,To observe the clinical effect of modified Tuduzi Buqi Decoction combined with western medicine conventional therapy on the treatment of refractory ascites in liver cirrhosis.,Methods,2,Fifty-seven patients with refractory ascites in liver cirrhosis were divided into treatment group (,n,=32) and control group (,n,=25). The control group was administered with western medicine conventional therapy, while the treatment group was additionally administered with Tuduzi Buqi Decoction besides the western medicine conventional therapy. The course of treatment in both groups lasted 14 days. We compared the changes of ascites related indicators (24-hour urine volume, body mass, abdominal circumference, and ascites depth in supine position) and laboratory related indicators (liver function, renal function, electrolyte, and coagulation function).,Results,2,①According to the intra-group comparison before and after 7 days of treatment, in the treatment group the 24-hour urine volume increased (,P,<,0.05), and the body mass, abdominal circumference, and depth of ascites in supine position decreased (,P,<,0.05). However, there was no significant difference in the above indicators in the control group (,P,>,0.05). According to the intra-group comparison before and after 14 days of treatment, there were significant differences in the above-mentioned ascites related indicators in both groups (,P,<,0.05). According to the inter-group comparison after 7 days of treatment and 14 days of treatment, there were significant differences in 24-hour urine volume and ascites depth in supine position between the two groups (,P,<,0.05). ②According to the intra-group comparison before and after 14 days of treatment, the serum creatinine level in the control group increased (,P,>,0.05), but there was no significant difference in indicators of liver function, renal function, electrolyte, and coagulation function in the treatment group (,P,>,0.05). According to the inter-group comparison after 14 days of treatment, there was no significant difference in the above indicators between the groups (,P,>,0.05).,Conclusion,2,Compared with the single use of western medicine conventional therapy, the combined use of Tuduzi Buqi Decoction and western medicine is more conducive to the resolution of refractory ascites in liver cirrhosis without increasing the risk of renal function injury and electrolyte disturbance.
肝硬化顽固性腹水徒都子补气汤肾功能电解质临床研究
liver cirrhosisrefractory ascitesTuduzi Buqi Decoctionkidney functionelectrolyteclinical research
徐小元,丁惠国,李文刚,等. 肝硬化腹水及相关并发症的诊疗指南[J]. 实用肝脏病杂志,2018, 21(1): 21-31.
中华医学会肺病学分会. 肝硬化诊治指南[J]. 现代医药卫生,2020, 36(2): 插1-插18.
王淑珍,丁惠园.肝硬化顽固性腹水新的治疗模式及理念[J]. 中华肝脏杂志,2017, 25(4): 249-253.
中国中西医结合学会消化系统疾病专业委员会. 肝硬化中西医结合诊疗共识[J]. 中国中西医结合消化杂志,2011, 19(4): 277-279.
RUNYON B A, AASLD. Introduction to the revised American Association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012[J]. Hepatology, 2013, 57(4): 1651-1653.
中国中西医结合学会消化疾病专业委员会. 肝硬化腹水的中西医结合诊疗共识意见[J]. 中国中西医结合杂志,2011, 31(9): 1171-1174.
佟印妮,黄艳册,郑吉敏. 肝硬化顽固性腹水的治疗[J]. 临床荟萃,2021, 36(1): 70-74.
毛以林. 步入中医之门2:被淡忘的经络辨证[M]. 北京:人民军医出版社,2019.
郭鹏,刘仕敬. 从三焦病辨治肝硬化腹水32例体会[J]. 山东中医药大学学报,1997, 21(4): 4-6.
0
浏览量
153
下载量
0
CSCD
6
CNKI被引量
关联资源
相关文章
相关作者
相关机构